Last updated: 2026-09-04 21:28:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Sunshine Biopharma Inc. (SBFM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.14, with a market capitalization of $4.54M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.01 to $24.30. This page covers its latest market performance, valuation, price trends and company information.
$4.54M | |
$1.12 | |
$310,000.00 | |
$1.01 | |
$1.11 | |
72.17K | |
-- | |
-- | |
$24.30 | |
$1.01 | |
-- | |
-- |
Sunshine Biopharma Inc. (SBFM) is trading at $1.14 in after-hours trading as of 2026-09-04 20:28:00, up 2.25% ($0.02) from the regular-session close of $1.11.
After-hours trading shows how investors are pricing SBFM after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Sunshine Biopharma Inc. (SBFM) moved from $1.14 to $1.14, representing a decline of 0.44% ($0.00).
The stock traded between $1.12 and $1.14 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 324.14 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.5%
SBFM is currently trading at $1.14, placing it 0.5% of the way from its 52-week low of $1.01 to its 52-week high of $24.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 50 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Sunshine Biopharma Inc. (SBFM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.